I see the future and the future is bright indeed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAGBF
Canopy Growth and ISOL now Business Partners
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
image: https://secure.gravatar.com/avatar/efef512aa26fa85b4c6b3400eedfbe52?s=128&d=mm&r=g
Written by Isodiol
Posted in Isodiol News
Tagged CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
image: https://isodiol.com/wp-content/uploads/2017/07/IINT-FB-Post-IsoInt-and-CanopyGrowth-licensing-REV.A.jpg
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Reply Quote Add Post To Favorites Follow Post
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26498420#vfeDo5QToeLHv9sz.99
Canopy Growth and ISOL now Business Partners $LAGBF
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
image: https://secure.gravatar.com/avatar/efef512aa26fa85b4c6b3400eedfbe52?s=128&d=mm&r=g
Written by Isodiol
Posted in Isodiol News
Tagged CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
image: https://isodiol.com/wp-content/uploads/2017/07/IINT-FB-Post-IsoInt-and-CanopyGrowth-licensing-REV.A.jpg
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Reply Quote Add Post To Favorites Follow Post
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26498420#vfeDo5QToeLHv9sz.99
For those of you who may have missed this News Release last week.
Canopy Growth and ISOL now Business Partners
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
image: https://secure.gravatar.com/avatar/efef512aa26fa85b4c6b3400eedfbe52?s=128&d=mm&r=g
Written by Isodiol
Posted in Isodiol News
Tagged CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
image: https://isodiol.com/wp-content/uploads/2017/07/IINT-FB-Post-IsoInt-and-CanopyGrowth-licensing-REV.A.jpg
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Reply Quote Add Post To Favorites Follow Post
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26498420#vfeDo5QToeLHv9sz.99
$LAGBF
Canopy Growth and ISOL now Business Partners
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
image: https://secure.gravatar.com/avatar/efef512aa26fa85b4c6b3400eedfbe52?s=128&d=mm&r=g
Written by Isodiol
Posted in Isodiol News
Tagged CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
image: https://isodiol.com/wp-content/uploads/2017/07/IINT-FB-Post-IsoInt-and-CanopyGrowth-licensing-REV.A.jpg
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
$LAGBF
Canopy Growth and ISOL now Business Partners
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
image: https://secure.gravatar.com/avatar/efef512aa26fa85b4c6b3400eedfbe52?s=128&d=mm&r=g
Written by Isodiol
Posted in Isodiol News
Tagged CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
image: https://isodiol.com/wp-content/uploads/2017/07/IINT-FB-Post-IsoInt-and-CanopyGrowth-licensing-REV.A.jpg
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26498420#3xOu1226Po0zc7xU.99
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
Written by
Isodiol
Posted in
Isodiol News
Tagged
CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution
Written by
Isodiol
Posted in
Isodiol News
Tagged
CanopyGrowthCorporation, InternationalDistribution, K-Cup, LicensingAgreement, MarijuanaInfused, Pot-O-Coco, Pot-O-Coffee, Pot-O-Tea
July 20, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED) (https://www.canopygrowth.com).
Canopy Growth is the world’s premier cannabis company that operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. Under this licensing agreement, Canopy Growth will have the right to manufacture and distribute the Company’s “Pot-O-Coffee“ and “Pot-O-Tea” branded marijuana infused single serve K-Cup products in Canada and certain other markets internationally as federal regulations allow. Licensed products include caffeinated and de-caffinated product lines as well as Isodiol’s single serve “Pot-O-Coco”. In addition to the Canadian rights, Canopy Growth shall have the right of first refusal to sell the “Pot-O” brand products in any territory outside of the US, Mexico and Puerto Rico.
“This distribution agreement has us positioned to increase our global footprint with the largest cannabis company in the world. We will continue to develop our Pot-O-Coffee product lines with ready to drink and cold brew products while working with Canopy Growth for international distribution channels. The Pot-O-Coffee brand is well recognized, and adding additional products to this line will continue to strengthen its market presence,” stated Isodiol’s CEO Marcos Agramont.
The availability of the various licensed products in Canada and elsewhere will differ depending on applicable laws and regulation. While Canadian law does not yet permit the manufacture and sale of marijuana infused products, the Company anticipates that such products will be permitted in the near future. Furthermore, currently proposed regulations which would permit the sale of infused products, would not allow such products to contain both marijuana and caffeine. As such, the specific product offerings in Canada and elsewhere may be limited. The Company will provide additional updates as regulations are adopted and as product roll-out plans are developed.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Face Book: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Good evening brother, I had a great weekend thanks for asking. Yesterday I went River Rafting, absolutely amazing!
$LAGBF https://isodiol.com/
If Isodiol keeps acheieving 14% growth every month (as they just did from May to June) we would be looking at $44.4 million in Revenue, if they could achieve say 20% in net income (In reality we will have to see their performance on the next quarterly) they would have an EPS of $0.05 using a P/E of 20, we would arrive at an SP of $1.03, P/E of 40 we get $2.06 per share - P/E will be high in this industry since all these companies are aniticipating a lot of growth.
If they Achieve 10% growth per month, we get $43 million in Revenue for the year and we're looking at an SP of $0.99 and $1.98 using the same approach (EPS $0.05 and PE 20 and 40 respectively)
If they achieve 10% growth per quarter, we get $24.5 million in Revenue for the year and we're looking at an SP of $0.57 and $1.14 (EPS $0.03 and P/E 20 and 40 respectively).
Here's a Video on the Company from their head Doctor explaining the Significance of its product line.
$LAGBF Here's a great Video with the Doctor from Isodiol Explaining the significance of their Product Line.
$LAGBF Here's a great Video with the Doctor from Isodiol Explaining the significance of their Product Line.
$LAGBF Here's a great Video with the Doctor from Isodiol Explaining the significance of their Product Line.
$LAGBF More Video's, I think its important to watch all the Video to get a better understanding to just how impressive this company is overall.
More $LAGBF Products.
$LAGBF the World's 1st CBD Infused Water, great video.
$LAGBF Here's a Great Video with the Doctor explaining why Isodiol has the Highest Quality Products in the Market Place.
Fantastic Video on $LAGBF
ISOL Records June Sales of $1,843,173
Isodiol International Inc. Announces Corporate Update
VANCOUVER, July 11, 2017 /CNW/ - Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the thirty-day period ended June 30, 2017. Total quarterly sales were $4,919,693 CAD for the period April 1st to June 30th, 2017.
Isodiol International CEO Marcos Agramont stated, "We continue to expand our domestic footprint and expand our distribution channels for our product lines. Month over month, we have grown by 10% and will continue to expand our sales and marketing team. With the progress we have made in Latin America and with our domestic growth, we are very excited entering the second half of 2017."
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabinoids, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26454413#cLDWG1VFEcAZMgBQ.99
Yes those are my thoughts also, I also really like the fact that $LAGBF has never had a big run as of yet. Its just not a well know company but from what I've been seeing with their news this week it looks like that's all about to change IMHO.
Hey Maddstacker have you seen this company $LAGBF? This company is currently doing nearly $1.7 Million a month in revenue and growing by the day.
I truly do believe that this is the most undervalued Marijuana stock in Canada right now IMHO. Check out this video when you have a minute. I wouldn't mind hearing your thoughts. Cheers
ISOL Video
I've bought over the last several days, I like this company and I bought it for the fundamentals. I truly believe that this could be a serious contender in the sector.
Looks great at these levels boys.
$LAGBF Video, I think that you will find this very impressive. The month revenues are growing and growing.
At the end of the day I truly do believe that this is the most undervalued Company within this sector IMHO.
Here's a Video on the company.
$LAGBF News
Isodiol International Inc. establishes operations in Mexico and will commence shipment of Cannabinol products
LAGBF, C.ISOL | 57 minutes ago
Canada NewsWire
VANCOUVER, June 21, 2017
VANCOUVER, June 21, 2017 /CNW/ - Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has established operations in Mexico and will commence shipment of its Cannabinol products throughout Mexico within the coming weeks.
With the Monday June 19 th, 2017 announcement by Mexican President Enrique Pena Nieto, Mexico has now officially legalized Medical Marijuana. The bill legalizes the buying, selling, importing and exporting of cannabis products with less than 1% THC. Cannabis related products are now available for medical use and gives people in Mexico access to products containing THC for the first time.
CEO of Isodiol International Inc. Marcos Agramont stated, "Anticipating the medical cannabis legalization in Mexico, we have spent the last few months investing in infrastructure to expand our distribution into that market. Through our online sales platform, we will immediately be able to commence distribution and build a footprint within Mexico. We will also continue to work through the approval process with Comision Federal para la Proteccion contra Riesgos Sanitarios ("COFEPRIS") for our manufacturing permit which will allow us to produce in Mexico. This is a very important step for us, as we continue to build out a fully vertically integrated operation, which is being replicated domestically and in every market we enter."
The company will provide additional information in the coming weeks.
About Isodiol International Inc.
Isodiol International, Inc. is a market leader in pharmaceutical grade cannabis compounds and a leading manufacturer and developer of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology utilized in the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development and production of over-the-counter and pharmaceutical products, continued expansion of its current sales channels, engaging in joint ventures and acquisitions to expand its portfolio of brands. Isodiol and its subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"
CEO & Director
Read more at http://www.stockhouse.com/news/press-releases/2017/06/21/isodiol-international-inc-establishes-operations-in-mexico-and-will-commence#0keB2HsHQdyvTKKg.99
Thanks for Sharing the symbol MICK, I like the company and I think it has huge potential.
Here's an article from the New York show they we're just at, it looks like things went very well down there.
Former Jets DE Marvin Washington, state Sen. Diane Savino on crusade to destigmatize cannabis
Ex-Jet DE Washington, state Senator work to destigmatize cannabis
BY Christian Red
NEW YORK DAILY NEWS
Updated: Sunday, June 18, 2017, 1:47 AM
facebook
Tweet
email
image: http://assets.nydailynews.com/polopoly_fs/1.3255033.1497707917!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannabis.jpg
image: http://assets.nydailynews.com/polopoly_fs/1.3255033.1497707917!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannabis.jpg
State Senator Diane Savino with former Jets defensive end Marvin Washington with Isodiol products.
(Howard Simmons/New York Daily News)
BY Christian Red
NEW YORK DAILY NEWS
Updated: Sunday, June 18, 2017, 1:47 AM
Manhattan’s Jacob Javits Center’s northernmost corner is a vast maze of booths teeming with cannabis advocates – all part of the fourth annual Cannabis World Congress Expo – and right smack in the center of the maw is New York State Senator Diane Savino, getting a crash education course on the Isodiol company’s hemp-based products. The lesson comes from none other than former Jets defensive end Marvin Washington.
It seems like an unlikely pair talking about the business of weed – the 53-year-old, Queens-born Savino and the still imposing, 51-year-old Washington, who is 6-6 and was born in Denver. But when it comes to the still growing cannabis movement, Savino and Washington are leading voices, and are on a parallel crusade to destigmatize pot, educate the public about the medical benefits of cannabis and most importantly, raise awareness about the opioid crisis plaguing cities and towns across the country.
“Stop using words like ‘weed’ and ‘pot,’ especially when you’re talking about medical cannabis,” says Savino, a Democrat who represents District 23, which includes parts of Staten Island and Brooklyn. “We have to change the way people think about it.”
For Washington, who played 11 years in the NFL and won a Super Bowl with the Broncos in 1999, he wants the NFL and the Players Association, and sports leagues in general, to embrace the cannabis movement, and specifically cannabidiol (CBD), the non-intoxicating compound in cannabis, as a safe alternative to treat debilitating sports injuries to the brain and body.
Ex-Jet wants level playing field for blacks in legal pot industry
Washington hopes the NFL and its union will pour more money into marijuana research in the future, and he says he thinks the two biggest problems plaguing the league – concussions/traumatic brain injuries and prescription painkiller abuse – would be mitigated significantly if players had access to marijuana, which is still classified by the federal government as a Schedule I drug.
“One thing in football – ex-players, they are fed opiates and pharmaceuticals throughout the week, from training camp until the end of season. That can be June to January. It’s not normal,” says Washington, the founder of Isodiol Performance products, which are THC-free, meaning they do not contain tetrahydrocannabinol, the component of cannabis that gets you high. “I think the Players Association should demand that (current players) have an alternative to opiates. This is scientific-based. This is not hocus pocus. That’s where I want to see this in the very near future, players that have an alternative to opiates and I would like CBD to be a part of that.”
Medical marijuana is now legal in 29 states, but Savino says the challenge for the cannabis movement remains the stigma that has been attached to marijuana for decades. Attorney General Jeff Sessions already sent a letter in May asking Congress to eliminate federal medical marijuana protections.
image: http://ntvcld-a.akamaihd.net/image/fetch/c_fill,w_727,h_445,f_auto/http://cdn.bttrack.com/li/727/445/143596
image: http://ntvcld-a.akamaihd.net/image/fetch/c_fill,w_727,h_445,f_auto/http://cdn.bttrack.com/li/727/445/143596
Paid Content by Microsoft
Guess who Gartner cites as a leader in data solutions?
“I write to renew the Department of Justice’s opposition to the inclusion of language in any appropriations legislation that would prohibit the use of Department of Justice funds or in any way inhibit its authority to enforce the Controlled Substances Act (CSA),” wrote Sessions.
Commissioner Roger Goodell still against marijuana use in NFL
image: http://assets.nydailynews.com/polopoly_fs/1.3255031.1497707914!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannibis.jpg
image: http://assets.nydailynews.com/polopoly_fs/1.3255031.1497707914!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannibis.jpg
Former Jet Marvin Washington at the Javits Center for Cannibis World Congress.
(Howard Simmons/New York Daily News)
Savino says she finds it “absurd” that the government still classifies marijuana as a controlled substance – meaning the government has determined marijuana has no accepted medical use – and she adds that the cannabis movement is being hampered by a government that is woefully behind the times. She also says “whoever invented (the painkiller) Oxycontin deserves a special place in hell.”
“Normally when you see legislation moving, state by state, at some point the feds catch up and they realize, ‘OK, this is something that we should get behind, or we should begin to regulate.’ But you have this almost willful ignorance on the part of the federal government with respect to cannabis policy in general,” says Savino, who sponsored the Compassionate Care Act, which passed in 2014 and established a “safe and regulated” medical marijuana program in New York state.
“The fact that (the federal government) continues to maintain that marijuana is a Schedule I substance, and that it is dangerous and has no redeemable value, is just absurd,” adds Savino.
While Savino is a staunch advocate for patients suffering from debilitating conditions like multiple sclerosis or post-traumatic stress disorder (PTSD) to be able to access medical marijuana, Marvin Washington continues to try and push the cannabis issue into the forefront of sports leagues, and advocating for acceptance of cannabis as a non-addictive means to treat chronic pain and other injuries, particularly those suffered by NFL players participating in a violent contact sport.
Why is it so hard to get medical marijuana in New York?
Washington says former NFL player Ricky Williams, the Heisman Trophy winner who tested positive for marijuana during his playing days and who was suspended an entire NFL season (2006) for violating the league’s drug policy, is an important voice in the cannabis movement and will be viewed as a “prophet” in the future for how he embraced marijuana use when he played.
“Ricky, 20 years from now, he’s going to look like a prophet. He was way ahead of his time. He wanted to play football but he didn’t want to medicate with opiates,” says Washington. “He was cutting edge. In 25 years, I believe you’re going to see cannabis and CBD endorsed by all major sports leagues and athletes. This is going to become a lifestyle choice for them.”
“I think the NFL is well aware of the growing movement of the acceptance of medical cannabis. Taking a less punitive approach toward the drug while investing in learning how cannabis can help players medically is a win win solution,” says Titans linebacker Derrick Morgan, one of the only current NFL players who has vocalized his support for the cannabis movement.
image: http://assets.nydailynews.com/polopoly_fs/1.3255032.1497707916!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannabis.jpg
image: http://assets.nydailynews.com/polopoly_fs/1.3255032.1497707916!/img/httpImage/image.jpg_gen/derivatives/article_1200/cannabis.jpg
Diane Savino takes part in radio broadcast.
(Howard Simmons/New York Daily News)
NFL commissioner Roger Goodell said earlier this year on ESPN’s “Mike and Mike” show that he was not in favor of removing marijuana from the league’s list of banned substances for recreational use.
Jeff Sessions wants to prosecute legal medical marijuana
“I think you still have to look at a lot of aspects of marijuana use,” Goodell told ESPN. “Is it something that can be negative to the health of our players? Listen, you’re ingesting smoke, so that’s not usually a very positive thing that people would say. It does have addictive nature.”
With regard to the NFL’s stance on investing money into marijuana research, or whether it would change its stance if marijuana was rescheduled, the league said in a statement to the Daily News: “We will continue to stay abreast of the science as it develops. We will always keep the health of the players as our priority in this and other medical matters.”
But with people like former Minnesota governor and professional wrestler Jesse Ventura, Republican political strategist Roger Stone and the civil rights leader Rev. Al Sharpton – all three were keynote speakers at the Cannabis World Congress along with Savino and Washington – adding their clout to the cannabis movement, the movement could shift to an industry in the future.
“There just needs to be education. My complaint with (the NFL) medical board is why don’t they have somebody that’s been studying this plant for years? Who owns the New York Jets? What’s Woody’s (Johnson) last name?” asks Washington, referring to the Jets owner who is the great-grandson of the co-founder of the Johnson & Johnson pharmaceutical giant.
Bill to allow medical pot use for PTSD sufferers clears Assembly
“They have a vested interest in keeping this organized lie that has been going on for 80 years. We have to go against it. People in the public eye can bring a lot of light to this issue,” adds Washington. “I’m going to continue to meet with more politicians, because the whole thing is education. They don’t know the difference between THC or TLC.”
Tags:
nfl
new york jets
marvin washington
diane savino
marijuana
medical marijuana
marijuana legalization
Send a Letter to the Editor
Read more at http://www.stockhouse.com/companies/bullboard?
Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26376606#lyxDs6hZ2paYJq8L.99
Isodiol International inc. commences approval process for its pharmaceutical products through the Brazilian Health Regulatory Agency (ANVISA)
Written by
Isodiol
Posted in
Isodiol News
Tagged
BrazilianMarket, CBDMovement, Isoderm, Nutraceutical, PharmaceuticalGradeCBD, SouthAmericanMarket
June 19, 2017 – Vancouver, Canada – Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has initiated the drug approval process through the Brazilian Health Regulatory Agency (ANVISA) for the approval of its pharmaceutical grade cannabidiol (CBD) products for placement in the Special Category List for approved imported CBD products.
As a part of the ANVISA approval process, the Company is also proud to announce physicians are currently prescribing the Isoderm product. “We are extremely excited to have officially entered the South American market for our pharmaceutical grade products,” said Marcos Agramont, Chief Executive Officer of Isodiol Inc.
“We anticipate receiving full approval within the next quarter, which allows us time to develop and implement our commercialization strategy for the Brazilian market. We will continue to develop products and sale channels in North America for our Nutraceutical products however, as the global CBD market evolves, we want to ensure Isodiol is at the forefront of this movement. As leaders in the domestic space, we will ensure Isodiol has a significant presence in the implementation of global standards with health authorities and government officials in turning this CBD movement into a legitimate industry,” said Marcos.
The company has also signed a non-binding letter of intent for an exclusive partnership agreement with an established Brazilian based pharmaceutical importer and distributor, who will provide the following services,
Obtain formal ANVISA approval for the products in Brazil,
Work exclusively with Isodiol for the importation, promotion, development and sale of products,
Sponsor events for physicians, distributors and pharmaceutical companies to spread awareness, educate and promote products.
Additional information will be provided around the financial terms of the partnership agreement in the coming weeks.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
$LAGBF and the NFL
Former Jets DE Marvin Washington, state Sen. Diane Savino on crusade to destigmatize cannabis
Tweet
email
State Senator Diane Savino with former Jets defensive end Marvin Washington with Isodiol products. (Howard Simmons/New York Daily News)
BY
Christian Red
NEW YORK DAILY NEWS
Updated: Sunday, June 18, 2017, 1:47 AM
Manhattan’s Jacob Javits Center’s northernmost corner is a vast maze of booths teeming with cannabis advocates – all part of the fourth annual Cannabis World Congress Expo – and right smack in the center of the maw is New York State Senator Diane Savino, getting a crash education course on the Isodiol company’s hemp-based products. The lesson comes from none other than former Jets defensive end Marvin Washington.
It seems like an unlikely pair talking about the business of weed – the 53-year-old, Queens-born Savino and the still imposing, 51-year-old Washington, who is 6-6 and was born in Denver. But when it comes to the still growing cannabis movement, Savino and Washington are leading voices, and are on a parallel crusade to destigmatize pot, educate the public about the medical benefits of cannabis and most importantly, raise awareness about the opioid crisis plaguing cities and towns across the country.
“Stop using words like ‘weed’ and ‘pot,’ especially when you’re talking about medical cannabis,” says Savino, a Democrat who represents District 23, which includes parts of Staten Island and Brooklyn. “We have to change the way people think about it.”
For Washington, who played 11 years in the NFL and won a Super Bowl with the Broncos in 1999, he wants the NFL and the Players Association, and sports leagues in general, to embrace the cannabis movement, and specifically cannabidiol (CBD), the non-intoxicating compound in cannabis, as a safe alternative to treat debilitating sports injuries to the brain and body.
Ex-Jet wants level playing field for blacks in legal pot industry
Washington hopes the NFL and its union will pour more money into marijuana research in the future, and he says he thinks the two biggest problems plaguing the league – concussions/traumatic brain injuries and prescription painkiller abuse – would be mitigated significantly if players had access to marijuana, which is still classified by the federal government as a Schedule I drug.
“One thing in football – ex-players, they are fed opiates and pharmaceuticals throughout the week, from training camp until the end of season. That can be June to January. It’s not normal,” says Washington, the founder of Isodiol Performance products, which are THC-free, meaning they do not contain tetrahydrocannabinol, the component of cannabis that gets you high. “I think the Players Association should demand that (current players) have an alternative to opiates. This is scientific-based. This is not hocus pocus. That’s where I want to see this in the very near future, players that have an alternative to opiates and I would like CBD to be a part of that.”
Medical marijuana is now legal in 29 states, but Savino says the challenge for the cannabis movement remains the stigma that has been attached to marijuana for decades. Attorney General Jeff Sessions already sent a letter in May asking Congress to eliminate federal medical marijuana protections.
Paid Content by Microsoft
Guess who Gartner cites as a leader in data solutions?
“I write to renew the Department of Justice’s opposition to the inclusion of language in any appropriations legislation that would prohibit the use of Department of Justice funds or in any way inhibit its authority to enforce the Controlled Substances Act (CSA),” wrote Sessions.
Commissioner Roger Goodell still against marijuana use in NFL
Former Jet Marvin Washington at the Javits Center for Cannibis World Congress. (Howard Simmons/New York Daily News)
Savino says she finds it “absurd” that the government still classifies marijuana as a controlled substance – meaning the government has determined marijuana has no accepted medical use – and she adds that the cannabis movement is being hampered by a government that is woefully behind the times. She also says “whoever invented (the painkiller) Oxycontin deserves a special place in hell.”
“Normally when you see legislation moving, state by state, at some point the feds catch up and they realize, ‘OK, this is something that we should get behind, or we should begin to regulate.’ But you have this almost willful ignorance on the part of the federal government with respect to cannabis policy in general,” says Savino, who sponsored the Compassionate Care Act, which passed in 2014 and established a “safe and regulated” medical marijuana program in New York state.
“The fact that (the federal government) continues to maintain that marijuana is a Schedule I substance, and that it is dangerous and has no redeemable value, is just absurd,” adds Savino.
While Savino is a staunch advocate for patients suffering from debilitating conditions like multiple sclerosis or post-traumatic stress disorder (PTSD) to be able to access medical marijuana, Marvin Washington continues to try and push the cannabis issue into the forefront of sports leagues, and advocating for acceptance of cannabis as a non-addictive means to treat chronic pain and other injuries, particularly those suffered by NFL players participating in a violent contact sport.
Why is it so hard to get medical marijuana in New York?
Washington says former NFL player Ricky Williams, the Heisman Trophy winner who tested positive for marijuana during his playing days and who was suspended an entire NFL season (2006) for violating the league’s drug policy, is an important voice in the cannabis movement and will be viewed as a “prophet” in the future for how he embraced marijuana use when he played.
“Ricky, 20 years from now, he’s going to look like a prophet. He was way ahead of his time. He wanted to play football but he didn’t want to medicate with opiates,” says Washington. “He was cutting edge. In 25 years, I believe you’re going to see cannabis and CBD endorsed by all major sports leagues and athletes. This is going to become a lifestyle choice for them.”
“I think the NFL is well aware of the growing movement of the acceptance of medical cannabis. Taking a less punitive approach toward the drug while investing in learning how cannabis can help players medically is a win win solution,” says Titans linebacker Derrick Morgan, one of the only current NFL players who has vocalized his support for the cannabis movement.
Diane Savino takes part in radio broadcast. (Howard Simmons/New York Daily News)
NFL commissioner Roger Goodell said earlier this year on ESPN’s “Mike and Mike” show that he was not in favor of removing marijuana from the league’s list of banned substances for recreational use.
Jeff Sessions wants to prosecute legal medical marijuana
“I think you still have to look at a lot of aspects of marijuana use,” Goodell told ESPN. “Is it something that can be negative to the health of our players? Listen, you’re ingesting smoke, so that’s not usually a very positive thing that people would say. It does have addictive nature.”
With regard to the NFL’s stance on investing money into marijuana research, or whether it would change its stance if marijuana was rescheduled, the league said in a statement to the Daily News: “We will continue to stay abreast of the science as it develops. We will always keep the health of the players as our priority in this and other medical matters.”
But with people like former Minnesota governor and professional wrestler Jesse Ventura, Republican political strategist Roger Stone and the civil rights leader Rev. Al Sharpton – all three were keynote speakers at the Cannabis World Congress along with Savino and Washington – adding their clout to the cannabis movement, the movement could shift to an industry in the future.
“There just needs to be education. My complaint with (the NFL) medical board is why don’t they have somebody that’s been studying this plant for years? Who owns the New York Jets? What’s Woody’s (Johnson) last name?” asks Washington, referring to the Jets owner who is the great-grandson of the co-founder of the Johnson & Johnson pharmaceutical giant.
Bill to allow medical pot use for PTSD sufferers clears Assembly
“They have a vested interest in keeping this organized lie that has been going on for 80 years. We have to go against it. People in the public eye can bring a lot of light to this issue,” adds Washington. “I’m going to continue to meet with more politicians, because the whole thing is education. They don’t know the difference between THC or TLC.”
Tags:
nfl
new york jets
marvin washington
diane savino
marijuana
$LAGBF ISODIOL INTERNATIONAL INC. OVER SUBSCRIBES PRIVATE PLACEMENT AND CLOSES SECOND TRANCHE FOR TOTAL PROCEEDS OF $4,142,070 CDN
$LAGBF just might be the most Under Valued Marijuana Stock in the market, which is currently doing over $1.6 Million a Month in Revenue.
Watch this video to Learn More. Cheers
Thank you Mick, very appreciated. Here's the video on the company below for you all. $LAGBF
Your welcome, lets be honest a company doing this type of Revenue should be much higher than it is. It is only a matter of time until $LAGBF has its time in the sun.
Here's an amazing Video on the company, very impressive to say the least.
Here's a great Video on $LAGBF I recommend you watching this video, honestly the company is very impressive.
Here's one for you $LAGBF this company is currently doing nearly $1.7 Million a Month already with their sales. CBD and THC Product line. Here's their website https://isodiol.com/
Also they are in New York as we speak sponsoring this event, this a company that you should put on the watch list. LAGBF
Isodiol International takes major sponsorship role at the NY Cannabis World Congress & Business Expo
LAGBF, C.ISOL, ISOL | 17 hours ago
Canada NewsWire
VANCOUVER, June 14, 2017
VANCOUVER, June 14, 2017 /CNW/ - Isodiol International Inc.- (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce we are one of the key sponsors at the NY Cannabis World Congress & Business Expo this June 14-16.
This annual cannabis business event is held at the Jacob K. Javits Convention Center in NY and is the leading forum for doing business in one of the fastest growing industries in the United States.
"Isodiol is also honored to have Dr. Ron Aung-Din, a neurologist with over 35 years of experience in General Neurology and Neuro-Psychiatry, speaking about the positive benefits and advancements of phytocannabinoids and presenting IsoDerm, a premium product he developed along with the team at Isodiol," said Isodiol's CEO Marcos Agramont.
"Sponsoring this event along with having Dr. Ron Aung-Din present at the seminar, gives Isodiol key exposer to play an active roll in our industry and meet with global vendors and investors to speak firsthand with them about what we believe, which is, we are at the start of significant global operational highlights that will give our company a very strong foundation for customer engagement and retention, while accelerating Isodiol's pace of innovation and competitive differentiation moving forward, with our brands like CBD Naturals, Iso-Sport, CannaCeuticals CBD Skincream, and Pot-O-Coffee," said Agramont.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"
CEO & Director
Read more at http://www.stockhouse.com/news/press-releases/2017/06/14/isodiol-international-takes-major-sponsorship-role-at-the-ny-cannabis-world#H07TH7UIGMQkQFOW.99
Here's one for you $LAGBF this company is currently doing nearly $1.7 Million a Month already with their sales. CBD and THC Product line. Here's their website https://isodiol.com/
Also they are in New York as we speak sponsoring this event, this a company that you should put on the watch list. LAGBF
Isodiol International takes major sponsorship role at the NY Cannabis World Congress & Business Expo
LAGBF, C.ISOL, ISOL | 17 hours ago
Canada NewsWire
VANCOUVER, June 14, 2017
VANCOUVER, June 14, 2017 /CNW/ - Isodiol International Inc.- (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce we are one of the key sponsors at the NY Cannabis World Congress & Business Expo this June 14-16.
This annual cannabis business event is held at the Jacob K. Javits Convention Center in NY and is the leading forum for doing business in one of the fastest growing industries in the United States.
"Isodiol is also honored to have Dr. Ron Aung-Din, a neurologist with over 35 years of experience in General Neurology and Neuro-Psychiatry, speaking about the positive benefits and advancements of phytocannabinoids and presenting IsoDerm, a premium product he developed along with the team at Isodiol," said Isodiol's CEO Marcos Agramont.
"Sponsoring this event along with having Dr. Ron Aung-Din present at the seminar, gives Isodiol key exposer to play an active roll in our industry and meet with global vendors and investors to speak firsthand with them about what we believe, which is, we are at the start of significant global operational highlights that will give our company a very strong foundation for customer engagement and retention, while accelerating Isodiol's pace of innovation and competitive differentiation moving forward, with our brands like CBD Naturals, Iso-Sport, CannaCeuticals CBD Skincream, and Pot-O-Coffee," said Agramont.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"
CEO & Director
Read more at http://www.stockhouse.com/news/press-releases/2017/06/14/isodiol-international-takes-major-sponsorship-role-at-the-ny-cannabis-world#H07TH7UIGMQkQFOW.99
Isodiol International takes major sponsorship role at the NY Cannabis World Congress & Business Expo
LAGBF, C.ISOL, ISOL | 17 hours ago
Canada NewsWire
VANCOUVER, June 14, 2017
VANCOUVER, June 14, 2017 /CNW/ - Isodiol International Inc.- (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce we are one of the key sponsors at the NY Cannabis World Congress & Business Expo this June 14-16.
This annual cannabis business event is held at the Jacob K. Javits Convention Center in NY and is the leading forum for doing business in one of the fastest growing industries in the United States.
"Isodiol is also honored to have Dr. Ron Aung-Din, a neurologist with over 35 years of experience in General Neurology and Neuro-Psychiatry, speaking about the positive benefits and advancements of phytocannabinoids and presenting IsoDerm, a premium product he developed along with the team at Isodiol," said Isodiol's CEO Marcos Agramont.
"Sponsoring this event along with having Dr. Ron Aung-Din present at the seminar, gives Isodiol key exposer to play an active roll in our industry and meet with global vendors and investors to speak firsthand with them about what we believe, which is, we are at the start of significant global operational highlights that will give our company a very strong foundation for customer engagement and retention, while accelerating Isodiol's pace of innovation and competitive differentiation moving forward, with our brands like CBD Naturals, Iso-Sport, CannaCeuticals CBD Skincream, and Pot-O-Coffee," said Agramont.
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"
CEO & Director
Read more at http://www.stockhouse.com/news/press-releases/2017/06/14/isodiol-international-takes-major-sponsorship-role-at-the-ny-cannabis-world#H07TH7UIGMQkQFOW.99
LAGBF is a Symbol that everyone should be watching.
I think its time for you guys to have a look at $LAGBF, they are currently doing over $1.6 Million a Month in Revenue and only getting stronger by the month. Here's a News Release.
sales at $1.61-million
2017-06-05 13:19 ET - News Release
Released its unaudited consolidated sales figures for the month of May, 2017. The company recorded sales of $1,615,694 for the 30-day period ended May 31, 2017. The sales were generated primarily from its wholly owned subsidiaries, including Isodiol International, acquired in the middle of the month. With the inclusion of Isodiol's internationally recognized market brand names as well as its recently developed direct sales channel, the company is well poised to expand its market share.
"We believe we are at the beginning of some significant global operational highlights that will give us a solid foundation for customer engagement and retention, while accelerating Laguna's pace of innovation and competitive differentiation, for a foundation of strong profitability and revenue growth in 2017," said Laguna Blends' chief executive officer, Marcos Agramont. "I am extremely optimistic about our company's worldwide growth opportunities and long-term vision as a leader in the distribution of healthy cannabis-based products."
Laguna will be attending the Cannabis World Congress and Business Expo in New York from June 14 to June 16, 2017, and looks forward to substantive dialogue with distributors and institutional investors as it continues to develop its various sales channels and brand awareness. Additional information on this will be provided in the coming week.
The company also announces the appointment of Aman Parmar to its board of directors. His corporate experience includes 12 years working with both public and private companies in the health care, resource, manufacturing and real estate sectors. Mr. Parmar has extensive experience in the capital markets and has been involved in corporate restructurings and financings for both public and private companies. He obtained a chartered accountant designation in 2012 and holds a bachelor of technology in accounting from the British Columbia Institute of Technology.
Mr. Parmar stated: "As we move forward and develop as an organization, I'm very excited to be a part of this immense opportunity. Laguna is positioned in becoming a global leader in the cannabis industry in the very near future."
Laguna will be providing additional operational updates in the coming week.
About Laguna Blends Inc.
Laguna Blends is a market leader in the distribution of cannabis-based products. Laguna's growth strategy includes acquiring and incubating companies that formulate and/or manufacture cannabis products. Laguna provides the highest-quality products and experience for consumers, utilizing a proprietary nanotechnology in its consumable and topical skin care products. Laguna is currently seeking joint ventures and acquisitions to expand its portfolio and will aggressively continue its international expansion into Latin America, Asia and Europe throughout 2017.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
Plus this company is already doing $1.7 Million Dollars in Monthly Revenue.
Honestly this is the most Undervalued Marijuana Company in the Public Markets right now.
Conor McGregor and Michael Bisping have the same Manager
Obviously the deal would have had to have gone through Michael Bispings Manager to get this deal done.
I can see it now Conor McGregor working with Imagination Park for his upcoming fight with Floyd Mayweather.
Floyd Mayweather vs Conor McGregor head-to-head: How the superstars match up ahead of proposed June 10 mega fight in Las Vegas
Floyd Mayweather and Conor McGregor are set to meet in Las Vegas on June 10
The two men will meet in a boxing match in Nevada, pocketing $100million each
Mayweather is five-weight world champion, McGregor has won in two divisions
Sportsmail takes you through the tale of the tape ahead of the big bout
READ: Jeff Powell looks ahead to the bout between Mayweather and McGregor
Read more at http://www.stockhouse.com/companies/bullboard/c.ip/imagination-park-entertainment-inc?postid=25976049#8lktZvc3YmGioGcd.99